The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Caspase activation precedes and leads to tangles
Open accessAbstract
Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death, severe cytological abnormalities, and markers of caspase activation and apoptosis, leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational- and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent evidence suggests that executioner caspases 3 and 7 may contribute to tau, the protein responsible for forming NFTs, pathology by cleaving tau after Asp421 to yield a cytotoxic Δtau fragment (Rissman et al., 2004; Rohn et al., 2008; de Calignon et al., 2010).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“may contribute to cognitive decline”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the early cleavage of tau by these caspases initiates tau aggregation and phosphorylation”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
In the citing paper
“Mitochondrial abnormalities, synaptic loss and dysfunction, altered axonal transport, and activation of cell death pathways (including caspase activation and inflammatory responses) have all been directly or indirectly implicated as consequences of tau mislocalization or oligomerization (20, 40, 43–52).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“For example, through direct visualization of the cortex of Tg4510 P301L mice by multiphoton microscopy, Hyman and colleagues were able to determine that caspase activation, and neuronal death, appeared in many instances to precede tangle formation.”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Indeed, tangles forming did not lead to neuronal death over the course of the several-month imaging period (43, 51).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Recent data suggest that intracellular protein aggregates of tau have the capacity to seed aggregation of native tau proteins and might propagate their misfolded state in a prion-like manner.”
From Propagation of Tau Pathology in a Model of Early Alzheimer's Disease (2012) · cites this paper as de Calignon et al., 2010
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [266]
In the citing paper
“whereas tau tangles alone are not sufficient to cause neuronal death”
From Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models (2019) · cites this paper as de Calignon et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Self-citationControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Self-citationAugustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
Self-citationCaspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702
Self-citationTau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 525
The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
Tanokashira, D., Mamada, N., Yamamoto, F., Taniguchi, K., Tamaoka, A., Lakshmana, M. K., & Araki, W. (2017) · Molecular Brain · doi:10.1186/s13041-016-0284-5 · Cited by 59
Regulation of Caspases in the Nervous System
Troy, C. M., Akpan, N., & Jean, Y. Y. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385504-6.00007-5 · Cited by 58
Caspase‐6 as a novel early target in the treatment of Alzheimer's disease
LeBlanc, A. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12250 · Cited by 56
Co-expression of truncated and full-length tau induces severe neurotoxicity
Özcelik, S., Sprenger, F., Skachokova, Z. K., Fraser, G., Abramowski, D., Clavaguera, F., Probst, A., Frank, S., Müller, M. M., Staufenbiel, M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.228 · Cited by 59
Kiprowska, M., Степанова, А., Todaro, D. R., Galkin, A. S., Haas, A. L., Wilson, S. M., & Figueiredo‐Pereira, M. E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.017 · Cited by 55
Means, J. C., Gerdes, B. C., Kaja, S., Sumien, N., Payne, A. J., Stark, D. A., Borden, P. K., Price, J. L., & Koulen, P. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1942-9 · Cited by 54
Li, Y., Dai, Y., Sun, J.-Y., Xiang, Y., Yang, J., Dai, S.-Y., & Zhang, X. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0645-z · Cited by 54
Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease
Jarero-Basulto, J. J., Luna‐Muñoz, J., Mena, R., Krištofíková, Z., Řípová, D., Perry, G. L., Binder, L. I., & García‐Sierra, F. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000013 · Cited by 55
Bondulich, M. K., Guo, T., Meehan, C., Manion, J., Martin, T. R., Mitchell, J. C., Hortobágyi, T., Yankova, N., Stygelbout, V., Brion, J., et al. (2016) · Brain · doi:10.1093/brain/aww137 · Cited by 52
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
de Gérando, A. M., Welikovitch, L. A., Khasnavis, A., Commins, C., Glynn, C. A., Chun, J. E., Perbet, R., & Hyman, B. T. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02600-1 · Cited by 54
Self-citationSustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy
Hunt, J. B., Nash, K. R., Placides, D. S., Moran, P., Selenica, M. B., Abuqalbeen, F., Ratnasamy, K., Slouha, N., Ospina, S. R., Savlia, M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3959-14.2015 · Cited by 57
Quintanilla, R. A., Tapia-Monsalves, C., Vergara, E. H., Maria Jose Perez, J., & Aránguiz, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00175 · Cited by 52
Hernández, F., Ferrer, I., Pérez, M., Zabala, J. C., del Rı́o, J. A., & Ávila, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.024 · Cited by 49
Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment
LeBlanc, A. C., Ramcharitar, J., Afonso, V. M., Hamel, É., Bennett, D. A., Pakavathkumar, P., & Albrecht, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.194 · Cited by 51
Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat
d’Orange, M., Aurégan, G., Cheramy, D., Gaudin, M., Lieger, S., Guillermier, M., Stimmer, L., Joséphine, C., Hérard, A., Gaillard, M., et al. (2017) · Brain · doi:10.1093/brain/awx342 · Cited by 57
Sandusky‐Beltran, L. A., Kovalenko, A., Ma, C., Calahatian, J. I. T., Placides, D. S., Watler, M., Hunt, J. B., Darling, A. L., Baker, J. D., Blair, L. J., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0507-y · Cited by 51
Canepa, E., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Gamallo‐Lana, B., Guzman‐Hernandez, R. A., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13063 · Cited by 54
FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD
Orozco, D., & Edbauer, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1077-2 · Cited by 52
The self-perpetuating tau truncation circle
Žilka, N., Kováčech, B., Baráth, P., Kontseková, E., & Novák, M. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120015 · Cited by 56
Song, H., Demirev, A. V., Kim, N., Kim, D., & Yoon, S. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.007 · Cited by 50
Lund, H., Cowburn, R. F., Gustafsson, E., Strömberg, K., Svensson, A., Dahllund, L., Malinowsky, D., & Sunnemark, D. (2012) · Brain Pathology · doi:10.1111/bpa.12001 · Cited by 49
Messing, L., Decker, J. M., Joseph, M., Mandelkow�, E., & Mandelkow, E.-M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.024 · Cited by 48
Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy
Kopeikina, K. J., Wegmann, S., Pitstick, R., Carlson, G. A., Bacskai, B. J., Betensky, R. A., Hyman, B. T., & Spires‐Jones, T. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080834 · Cited by 48
Self-citationMeans, J. C., Venkatesan, A., Gerdes, B. C., Fan, J.-Y., Bjes, E. S., & Price, J. L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005171 · Cited by 48
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Foidl, B. M., & Humpel, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00113 · Cited by 47
Polydoro, M., de Calignon, A., Suárez‐Calvet, M., Sanchez, L., Kay, K. R., Nicholls, S. B., Roe, A. D., Pitstick, R., Carlson, G. A., Gómez‐Isla, T., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0881-13.2013 · Cited by 47
Self-citationNMDA receptors and BAX are essential for Aβ impairment of LTP
Olsen, K. M., & Sheng, M. (2012) · Scientific Reports · doi:10.1038/srep00225 · Cited by 47
Žilková, M., Žilka, N., Kováč, A., Kováčech, B., Škrabana, R., Skrabanova, M., & Novák, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101434 · Cited by 45
Strategic Role for Mitochondria in Alzheimer's Disease and Cancer
Hedskog, L., Zhang, S., & Ankarcrona, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4259 · Cited by 45
Giustiniani, J., Guillemeau, K., Dounane, O., Sardin, E., Huvent, I., Schmitt, A., Hamdane, M., Buée, L., Landrieu, I., Lippens, G. M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-268243 · Cited by 48
Zwang, T. J., Sastre, E. D., Wolf, N., Ruiz-Uribe, N., Woost, B., Hoglund, Z., Fan, Z., Bailey, J., Nfor, L., Buée, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114574 · Cited by 48
Self-citationAdeosun, S. O., Hou, X., Zheng, B., Stockmeier, C. A., Ou, X., Paul, I. A., Mosley, T. H., Weisgraber, K. H., & Wang, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497909 · Cited by 47
Characterization of TauC3 antibody and demonstration of its potential to block tau propagation
Nicholls, S. B., DeVos, S. L., Commins, C., Nobuhara, C. K., Bennett, R. E., Corjuc, D. L., Maury, E. A., Eftekharzadeh, B., Akingbade, O., Fan, Z., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177914 · Cited by 46
Self-citationQ&A: Cellular near death experiences—what is anastasis?
Sun, G., & Montell, D. J. (2017) · BMC Biology · doi:10.1186/s12915-017-0441-z · Cited by 44
Neuropathology of the Alzheimer's continuum: an update
Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52
Huin, V., Buée, L., Behal, H., Labreuche, J., Sablonnière, B., & Dhaenens, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-12955-7 · Cited by 43
Initiation and propagation of neurodegeneration
Haass, C. (2010) · Nature Medicine · doi:10.1038/nm.2223 · Cited by 45
Tau and Caspase 3 as Targets for Neuroprotection
Idan-Feldman, A., Ostritsky, R., & Gozes, I. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/493670 · Cited by 42
Caspases: Therapeutic Targets in Neurologic Disease
Troy, C. M., & Jean, Y. Y. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0307-9 · Cited by 42
Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases
Eftekharzadeh, B., Hyman, B. T., & Wegmann, S. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.001 · Cited by 44
Self-citationAmadoro, G., Latina, V., Corsetti, V., & Calissano, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165584 · Cited by 44
Li, L., Liang, J., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.020 · Cited by 42
Anastasis: Return Journey from Cell Death
Zaitceva, V., Kopeina, G. S., & Zhivotovsky, B. (2021) · Cancers · doi:10.3390/cancers13153671 · Cited by 41
Sotiropoulos, I., Silva, J. M., Kimura, T., Rodrigues, A. J., Costa, P., Almeida, O. F. X., Sousa, N., & Takashima, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140693 · Cited by 40
Amadoro, G., Corsetti, V., Sancesario, G. M., Lubrano, A., Melchiorri, G., Bernardini, S., Calissano, P., & Sancesario, G. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140267 · Cited by 43
Pérez, P. D., Hall, G., Kimura, T., Ren, Y., Bailey, R. M., Lewis, J. M., Febo, M., & Sahara, N. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-9 · Cited by 41
Selenica, M.-L. B., Davtyan, H., Housley, S. B., Blair, L. J., Gillies, A., Nordhues, B. A., Zhang, B., Liu, J., Gestwicki, J. E., Lee, D. C., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0152-0 · Cited by 40
A Shift to Organismal Stress Resistance in Programmed Cell Death Mutants
Judy, M. E., Nakamura, A., Huang, A., Grant, H. E., McCurdy, H., Weiberth, K. F., Gao, F., Coppola, G., Kenyon, C. J., & Kao, A. W. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003714 · Cited by 40
Miller, N., Feng, Z., Edens, B. M., Yang, B., Shi, H., Sze, C. C., Hong, B. T., Su, S. C., Cantú, J. A., Topczewski, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3716-14.2015 · Cited by 41
Invited review: Drug development for tauopathies
Grüninger, F. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12192 · Cited by 40
Hyman, B. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-023749 · Cited by 39
Self-citationAzure C Targets and Modulates Toxic Tau Oligomers
Cascio, F. L., & Kayed, R. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00501 · Cited by 41
Metcalfe, M., Huang, Q., & Figueiredo‐Pereira, M. E. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.70 · Cited by 38
Shimojo, M., Higuchi, M., Suhara, T., & Sahara, N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00482 · Cited by 37
Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model
Manucat-Tan, N. B., Shen, L.-L., Bobrovskaya, L., Al‐Hawwas, M., Zhou, F. H., Wang, Y., & Zhou, X. (2019) · Aging · doi:10.18632/aging.102202 · Cited by 36
Pioglitazone prevents tau oligomerization
Hamano, T., Shirafuji, N., Makino, C., Yen, S.-H. C., Kanaan, N. M., Ueno, A., Suzuki, J., Ikawa, M., Matsunaga, A., Yamamura, O., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.016 · Cited by 37
A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo
Bardai, F. H., Wang, L., Mutreja, Y., Yenjerla, M., Gamblin, T. C., & Feany, M. B. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1550-17.2017 · Cited by 37
Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Chu, D., Yang, X., Wang, J., Zhou, Y., Gu, J., Miao, J., Wu, F., & Liu, F. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385853 · Cited by 39
Zhou, L., Flores, J., Noël, A., Beauchet, O., Sjöström, P. J., & LeBlanc, A. C. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0856-6 · Cited by 36
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 41
Liebscher, S., & Meyer‐Luehmann, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00026 · Cited by 36
Sources of Extracellular Tau and its Signaling
Ávila, J., Simón, D., Díaz-Hernández, M., Pintor, J. J., & Hernández, F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131832 · Cited by 36
C/EBPβ/AEP Signaling Drives Alzheimer’s Disease Pathogenesis
Xiong, J., Zhang, Z., & Ye, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01025-w · Cited by 37
Hu, J., Sha, W., Yuan, S., Wu, J., & Huang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915023 · Cited by 40
Caspase activation without apoptosis: insight into Aβ initiation of neurodegeneration
Hyman, B. T. (2010) · Nature Neuroscience · doi:10.1038/nn0111-5 · Cited by 34
Self-citationSaidi, L.-J., Polydoro, M., Kay, K. R., Sanchez, L., Mandelkow, E., Hyman, B. T., & Spires‐Jones, T. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142094 · Cited by 34
Self-citationNeuropathology of Alzheimer's Disease and its Variants
Duyckaerts, C. J., & Dickson, D. W. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch10 · Cited by 36
Lépine, S., Nauleau-Javaudin, A., Deneault, É., Chen, C. X. ‐., Abdian, N., Franco-Flores, A. K., Haghi, G., Castellanos‐Montiel, M. J., Maussion, G., Chaineau, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109166 · Cited by 40
Relationship between Serum Levels of Tau Fragments and Clinical Progression of Alzheimer's Disease
Henriksen, K., Byrjalsen, I., Christiansen, C., & Karsdal, M. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140984 · Cited by 34
Trained Innate Immunity Not Always Amicable
Włodarczyk, M., Druszczyńska, M., & Fol, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102565 · Cited by 34
Latina, V., Giacovazzo, G., Cordella, F., Balzamino, B. O., Micera, A., Varano, M., Marchetti, C., Malerba, F., Florio, R., Ercole, B. B., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01138-1 · Cited by 33
Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 36
Méduri, G., Guillemeau, K., Dounane, O., Sazdovitch, V., Duyckaerts, C. J., Chambraud, B., Baulieu, E. E., & Giustiniani, J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.017 · Cited by 33
Ávila, J. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.157 · Cited by 33
Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging
Wu, Q., Lin, Y., Gu, J., & Sigurdsson, E. M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.041 · Cited by 31
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32
Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP
Nadel, C. M., Pokhrel, S., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52075-1 · Cited by 36
Flunkert, S., Hierzer, M., Löffler, T., Rabl, R., Neddens, J., Duller, S., Schofield, E., Ward, M. A., Posch, M., Jungwirth, H., et al. (2012) · Neurodegenerative Diseases · doi:10.1159/000338152 · Cited by 32
Angel, A., Volkman, R., Royal, T. G., & Offen, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031144 · Cited by 30
Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy
Ridler, T., Witton, J., Phillips, K. G., Randall, A. D., & Brown, J. T. (2020) · eLife · doi:10.7554/elife.59045 · Cited by 29
Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy
McGeachan, R. I., Keavey, L., Simzer, E. M., Chang, Y. Y., Rose, J. L., Spires-Jones, M. P., Gilmore, M., Holt, K., Meftah, S., Ravingerova, N., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01992-5 · Cited by 38
Self-citationGiong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 31
Involvement of endoplasmic reticulum stress in tauopathy
Sakagami, Y., Kudo, T., Tanimukai, H., Kanayama, D., Omi, T., Horiguchi, K., Okochi, M., Imaizumi, K., & Takeda, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.007 · Cited by 29
A Simple Model to Study Tau Pathology
Houck, A. L., Hernández, F., & Ávila, J. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25100 · Cited by 29
Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry
Huang, R. Y. ‐., Iacob, R. E., Sankaranarayanan, S., Yang, L., Ahlijanian, M. K., Tao, L., Tymiak, A. A., & Chen, G. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1815-8 · Cited by 30
López‐González, I., Carmona, M., Blanco, R., Luna‐Muñoz, J., Martínez‐Mandonado, A., Mena, R., & Ferrer, I. (2013) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00627.x · Cited by 28
Teravskis, P. J., Ashe, K. H., & Liao, D. (2020) · The Neuroscientist · doi:10.1177/1073858420916696 · Cited by 31
Friend or foe: role of pathological tau in neuronal death
Wu, M., Chen, Z., Jiang, M. H., Bao, B., Li, D., Yin, X., Wang, X., Liu, D., & Zhu, L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02024-z · Cited by 28
Gasperini, R., Hou, X., Parkington, H. C., Coleman, H., Klaver, D. W., Vincent, A. J., Foa, L. C., & Small, D. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-19 · Cited by 31
Long, Z., Zeng, Q., Wang, K., Sharma, A., & He, G. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw085 · Cited by 29
Convergent molecular defects underpin diverse neurodegenerative diseases
Tofaris, G. K., & Buckley, N. J. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316988 · Cited by 30
A Rapid Gene Delivery-Based Mouse Model for Early-Stage Alzheimer Disease-Type Tauopathy
Siman, R., Lin, Y., Malthankar‐Phatak, G. H., & Dong, Y. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000006 · Cited by 27
Ni, R., Chen, Z., Gerez, J., Shi, G., Zhou, Q., Riek, R., Nilsson, K. P. R., Razansky, D., & Klohs, J. (2020) · Biomedical Optics Express · doi:10.1364/boe.395803 · Cited by 22
Importance of the Caspase Cleavage Site in Amyloid-β Protein Precursor
Bredesen, D. E., John, V., & Galván, V. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100537 · Cited by 27
Ludvigson, A. E., Luebke, J. I., Lewis, J. M., & Peters, A. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0295-4 · Cited by 27
Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins
Zhang, X., & Ran, C. (2013) · Current Organic Chemistry · doi:10.2174/1385272811317060004 · Cited by 26
He, Q., Wu, B., Price, J. L., & Zhao, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040886 · Cited by 28
Girling, K., Demers, M., Lainé, J., Zhang, S., Wang, Y. T., & Graham, R. K. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24153 · Cited by 26
Post-Translational Modifications in Alzheimer's Disease and the Potential for New Biomarkers
Russell, C. L., Končarević, S., & Ward, M. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132312 · Cited by 26
Metadata
- Authors
- de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- McLaughlin Research Institute (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2010-03-31
- Volume
- 464
- Issue
- 7292
- Pages
- 1201-1204
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3091360
- OpenAlex
- W2100026237
- Cited by
- 517
- References
- 31
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 12 · 2023: 30 · 2022: 24 · 2021: 28 · 2020: 26 · 2019: 19 · 2018: 26 · 2017: 38 · 2016: 40 · 2015: 39 · 2014: 26 · 2013: 48 · 2012: 54
- FWCI
- 39.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- National Institute on Aging (AG-08487, R01AG026249, R01AG008487, AG026249, P50AG005134, K99AG033670, P30AG062421)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- caspase activation, neurofibrillary tangles, tau protein, Alzheimer's disease, frontotemporal dementia, tau transgenic mice, neuronal survival, neurodegeneration, tau truncation, APOE ε4, APOE3, APOE2, APOE genotype, multiphoton imaging, tau aggregation
- MeSH terms
- Animals, Brain, Enzyme Activation, Humans, Mice, Transgenic, Neurons, Protein Processing, Post-Translational, Solubility, Time Factors, Neurofibrillary Tangles, tau Proteins, Cell Death, Caspases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
